Wordt geladen...
A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut‐allergic adolescents
Anti‐IgE treatments, such as omalizumab, have shown promising effects in allergy treatment. Our previous work has shown that individualized omalizumab treatment (OT) allows a safe initiation and rapid up‐dosing of peanut oral immunotherapy (OIT) in peanut‐allergic adolescents. However, the broader i...
Bewaard in:
| Gepubliceerd in: | Scand J Immunol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7988572/ https://ncbi.nlm.nih.gov/pubmed/33244763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/sji.13005 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|